TFS
PFE icon

Thoroughbred Financial Services’s Pfizer PFE Stock Holding History

Thoroughbred Financial Services’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$961K Buy
34,225
+11,750
+52% +$313K 0.06% 286
2025
Q4 		$559K Buy
22,475
+9,414
+72% +$237K 0.03% 357
2025
Q3 		$332K Sell
13,061
-959
-7% -$23.7K 0.02% 456
2025
Q2 		$339K Sell
14,020
-16,216
-54% -$378K 0.02% 441
2025
Q1 		$766K Buy
30,236
+3,339
+12% +$87.4K 0.05% 341
2024
Q4 		$713K Sell
26,897
-6,589
-20% -$179K 0.04% 341
2024
Q3 		$969K Buy
33,486
+1,313
+4% +$38.3K 0.06% 279
2024
Q2 		$900K Buy
32,173
+16,313
+103% +$449K 0.06% 286
2024
Q1 		$440K Sell
15,860
-12,505
-44% -$347K 0.04% 305
2023
Q4 		$816K Sell
28,365
-33,959
-54% -$1.03M 0.07% 279
2023
Q3 		$2.07M Sell
62,324
-15,799
-20% -$559K 0.2% 105
2023
Q2 		$2.87M Sell
78,123
-5,006
-6% -$195K 0.38% 63
2023
Q1 		$3.39M Sell
83,129
-1,195
-1% -$51.6K 0.5% 49
2022
Q4 		$4.32M Buy
84,324
+553
+0.7% +$26.5K 0.71% 30
2022
Q3 		$3.67M Buy
83,771
+194
+0.2% +$9.43K 0.7% 31
2022
Q2 		$4.38M Buy
83,577
+324
+0.4% +$16.5K 0.81% 25
2022
Q1 		$4.31M Buy
83,253
+40,257
+94% +$2.09M 0.7% 32
2021
Q4 		$2.54M Buy
42,996
+2,757
+7% +$137K 0.53% 37
2021
Q3 		$1.73M Sell
40,239
-15,594
-28% -$691K 0.42% 54
2021
Q2 		$2.19M Buy
55,833
+969
+2% +$37.7K 0.55% 43
2021
Q1 		$1.99M Buy
54,864
+5,623
+11% +$200K 0.55% 44
2020
Q4 		$1.81M Buy
49,241
+31,941
+185% +$1.17M 0.56% 45
2020
Q3 		$602K Sell
17,300
-1,014
-6% -$35.6K 0.23% 118
2020
Q2 		$568K Sell
18,314
-35,286
-66% -$1.2M 0.24% 114
2020
Q1 		$1.66M Buy
53,600
+506
+1% +$17.2K 0.59% 42
2019
Q4 		$1.97M Sell
53,094
-8,085
-13% -$288K 0.66% 40
2019
Q3 		$2.09M Sell
61,179
-3,459
-5% -$126K 0.79% 33
2019
Q2 		$2.66M Buy
64,638
+967
+2% +$38.4K 1.01% 26
2019
Q1 		$2.57M Sell
63,671
-1,249
-2% -$50K 1.06% 21
2018
Q4 		$2.69M Buy
+64,920
New +$2.69M 1.32% 19

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Thoroughbred Financial Services's PFE Position: Q1 2026 in Review

Thoroughbred Financial Services increased its Pfizer (PFE) stake by 52% in Q1 2026, buying an estimated $313K and bringing the position to 34,225 shares worth $961K. The position accounts for 0.06% of the portfolio, ranked #286.

Thoroughbred Financial Services first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $4.38M in Q2 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Thoroughbred Financial Services held 34,225 shares of Pfizer worth $961K as of Q1 2026.
  • Thoroughbred Financial Services bought 11,750 Pfizer shares in Q1 2026, an estimated $313K.
  • Pfizer made up 0.06% of Thoroughbred Financial Services's portfolio in Q1 2026, its #286 holding.
  • Thoroughbred Financial Services first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
  • Thoroughbred Financial Services's Pfizer position peaked at $4.38M in Q2 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Thoroughbred Financial Services's 13F filing for Q1 2026, filed 12 May 2026.